SONASID S.A. (CBSE:SID)
2,450.00
+4.00 (0.16%)
At close: Aug 8, 2025
Oncternal Therapeutics Revenue
In the year 2024, SONASID had annual revenue of 5.49B MAD with 9.98% growth. SONASID had revenue of 2.45B in the half year ending December 31, 2023, with 0.16% growth.
Revenue
5.49B
Revenue Growth
+11.37%
P/S Ratio
1.74
Revenue / Employee
8.47M
Employees
649
Market Cap
9.56B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.49B | 498.71M | 9.98% |
Dec 31, 2023 | 5.00B | 107.63M | 2.20% |
Dec 31, 2022 | 4.89B | 394.25M | 8.77% |
Dec 31, 2021 | 4.49B | 1.34B | 42.54% |
Dec 31, 2020 | 3.15B | -469.27M | -12.96% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Attijariwafa bank | 31.93B |
Itissalat Al-Maghrib (IAM) | 36.48B |
Managem | 8.86B |
TAQA Morocco | 10.86B |
Société d'Exploitation des Ports | 5.01B |
Banque Centrale Populaire | 20.05B |
Bank of Africa | 16.06B |
LafargeHolcim Maroc | 8.15B |